Supplier
BIOGEN PORTUGAL- SOC.FARMAC., LDA
LISBOA · PRT
Track this recordWith Adjudera Pro, get alerted before a contract here runs out.
Awards
3
Total awarded
€476k
3 / 3 with a value
Buyers
1
Sectors
1
Group: Biogen GmbH(inferred)
Reg. 506415740
Contracts this supplier holds that are running out
4 May 2027
estimatedN190 - NATALIZUMAB [150 MG/ 1 ML SOL INJ SERINGA]€57,941Unidade Local de Saúde Santa Maria, E.P.E.BIOGEN PORTUGAL- SOC.FARMAC., LDA
10 May 2027
estimatedN190 - NATALIZUMAB [150 MG/ 1 ML SOL INJ SERINGA]€178,280Unidade Local de Saúde Santa Maria, E.P.E.BIOGEN PORTUGAL- SOC.FARMAC., LDA
1 Jun 2027
estimatedI957 - INTERFERÃO BETA-1A [6 MUI 0,5 ML IM CANETA]€240,235Unidade Local de Saúde Santa Maria, E.P.E.BIOGEN PORTUGAL- SOC.FARMAC., LDA
Awards
| Awarded | Buyer | Winner | Contract value | Published |
|---|---|---|---|---|
| N190 - NATALIZUMAB [150 MG/ 1 ML SOL INJ SERINGA] | Unidade Local de Saúde Santa Maria, E.P.E. | BIOGEN PORTUGAL- SOC.FARMAC., LDA | €57,941 | 24 Oct 2026 |
| N190 - NATALIZUMAB [150 MG/ 1 ML SOL INJ SERINGA] | Unidade Local de Saúde Santa Maria, E.P.E. | BIOGEN PORTUGAL- SOC.FARMAC., LDA | €178,280 | 24 Oct 2026 |
| I957 - INTERFERÃO BETA-1A [6 MUI 0,5 ML IM CANETA] | Unidade Local de Saúde Santa Maria, E.P.E. | BIOGEN PORTUGAL- SOC.FARMAC., LDA | €240,235 | 24 Oct 2026 |